Abstract 544: Dissecting the biological functions of various isoforms of ferredoxin reductase for cell survival and DNA damage response.

Abstract The ferredoxin reductase (FDXR) gene is expressed as seven isoforms: 1-6 by alternative splicing and 7 by alternative promoter. FDXR, primarily the reference mitochondrial isoform 1, is required for biosynthesis of sterols, heme and iron-sulfur clusters, but isoforms 2-7 are undefined. Here, we found that isoform 1 is the most abundant one, accounting for ∼70% of total FDXR whereas isoforms 4 and 7 account for ∼10% and ∼7%, respectively. We found that isoforms 1 and 4 are mainly localized in the mitochondria whereas isoform 7, which lacks a mitochondria localization signal, is expressed in the cytosol. We also found that like the promoter for isoforms 1-6, the P2 promoter for isoform 7 can be induced by DNA damage in a p53-dependent manner. To determine isoform-specific activity, we generated multiple MCF7 cell lines in that one or more isoforms are knocked out. While total FDXR-KO MCF7 cells are non-viable, cells deficient in isoforms 1-6, isoforms 4 or 7 remain viable but are weak in cell proliferation, DNA damage response and repair. These data suggest that each FDXR isoform contributes to cell survival and that isoform 7 has an extra-mitochondrial activity sufficient for cell survival. Citation Format: Kenichi Nakajima, Shakur Mohibi, Kyle Kenji Hong, Xinbin Chen, Jin Zhang. Dissecting the biological functions of various isoforms of ferredoxin reductase for cell survival and DNA damage response [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 544.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2026-04-03
DOI
https://doi.org/10.1158/1538-7445.am2026-544
Primary Topic
Ferroptosis and cancer prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 544: Dissecting the biological functions of various isoforms of ferredoxin reductase for cell survival and DNA damage response.

Shakur Mohibi, Kenichi Nakajima, Kyle Kenji Hong, Jin Zhang et al.
Cancer Research
Ferroptosis and cancer prognosis
article

Abstract 544: Dissecting the biological functions of various isoforms of ferredoxin reductase for cell survival and DNA damage response.

Shakur Mohibi, Kenichi Nakajima, Kyle Kenji Hong, Jin Zhang, Xinbin Chen
article en

Abstract

Abstract The ferredoxin reductase (FDXR) gene is expressed as seven isoforms: 1-6 by alternative splicing and 7 by alternative promoter. FDXR, primarily the reference mitochondrial isoform 1, is required for biosynthesis of sterols, heme and iron-sulfur clusters, but isoforms 2-7 are undefined. Here, we found that isoform 1 is the most abundant one, accounting for ∼70% of total FDXR whereas isoforms 4 and 7 account for ∼10% and ∼7%, respectively. We found that isoforms 1 and 4 are mainly localized in the mitochondria whereas isoform 7, which lacks a mitochondria localization signal, is expressed in the cytosol. We also found that like the promoter for isoforms 1-6, the P2 promoter for isoform 7 can be induced by DNA damage in a p53-dependent manner. To determine isoform-specific activity, we generated multiple MCF7 cell lines in that one or more isoforms are knocked out. While total FDXR-KO MCF7 cells are non-viable, cells deficient in isoforms 1-6, isoforms 4 or 7 remain viable but are weak in cell proliferation, DNA damage response and repair. These data suggest that each FDXR isoform contributes to cell survival and that isoform 7 has an extra-mitochondrial activity sufficient for cell survival. Citation Format: Kenichi Nakajima, Shakur Mohibi, Kyle Kenji Hong, Xinbin Chen, Jin Zhang. Dissecting the biological functions of various isoforms of ferredoxin reductase for cell survival and DNA damage response [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 544.

Cancer ResearchVol. 86(7_Supplement)
University of California, Davis (US)
Openalex Percentile: Top 5%
Ferroptosis and cancer prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Abstract 544: Dissecting the biological functions of various isoforms of ferredoxin reductase for cell survival and DNA damage response. — Shakur Mohibi, Kenichi Nakajima, et al. · Cancer Research (2026) | TGRS Research Map | TGRS